BiotechTube
Home/Monte Rosa Therapeutics/Christopher R. L. Cline, CFA
CR

Christopher R. L. Cline, CFA

Chief Financial Officer

Monte Rosa Therapeutics

Therapeutic Areas

OncologyAutoimmune DiseasesNeurology

Monte Rosa Therapeutics Pipeline

DrugIndicationPhase
MRT-2359MYC-driven solid tumors and lymphomasPhase 1/2
MRT-6160Inflammatory and autoimmune diseasesPreclinical
CDK2 DegraderOncologyPreclinical

Leadership Team at Monte Rosa Therapeutics

DM
Dr. Markus Warmuth, M.D.
President, Chief Executive Officer, and Director
DS
Dr. Sharon Townson, Ph.D.
Chief Scientific Officer
PV
Philip Vickers, Ph.D.
Head of Research & Development
DA
Dr. Alison L. Hannah, M.D.
Chief Medical Officer
DJ
Dr. John Tsai, M.D.
Chair of the Board of Directors
DT
Dr. Thomas G. Wiggans
Director
DT
Dr. Thomas J. Kelly, M.D., Ph.D.
Director
DT
Dr. Thomas C. Reynolds, M.D., Ph.D.
Director
DT
Dr. Thomas B. Neff
Director
DB
Dr. Brenda Schulman
Scientific Advisory Board Member
View full Monte Rosa Therapeutics profile